Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors

Acta Neuropathologica

Volumn 131, Issue 6, 2016, Pages 847-863

  Rivera, Barbara ^a   Gayden, Tenzin ^a   Carrot Zhang, Jian ^a   Nadaf, Javad ^a   Boshari, Talia ^b   Faury, Damien ^a   Zeinieh, Michele ^a   Blanc, Romeo ^c   Burk, David L ^a   Fahiminiya, Somayyeh ^a   Bareke, Eric ^a   Schüller, Ulrich ^d   Monoranu, Camelia M ^e   Sträter, Ronald ^f   Kerl, Kornelius ^f   Niederstadt, Thomas ^f   Kurlemann, Gerhard ^f   Ellezam, Benjamin ^g   Michalak, Zuzanna ^h   Thom, Maria ^h   Lockhart, Paul J ^i,j   Leventer, Richard J ^i,j,k   Ohm, Milou ^l   MacGregor, Duncan ^k   Jones, David ^m   Karamchandani, Jason ⁿ   Greenwood, Celia M T ^a   Berghuis, Albert M ^a   Bens, Susanne ^o   Siebert, Reiner ^o   Zakrzewska, Magdalena ^p   Liberski, Pawel P ^p   Zakrzewski, Krzysztof ^q   Sisodiya, Sanjay M ^h,r   Paulus, Werner ^f   Albrecht, Steffen ^s   Hasselblatt, Martin ^f   Jabado, Nada ^a,s   Foulkes, William D ^a,b,t   Majewski, Jacek ^a   more..

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY OF MONTREAL   (Canada)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^k ROYAL CHILDREN'S HOSPITAL   (Australia)

^l VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ MCGILL UNIVERSITY   (Canada)

^o UNIVERSITY OF KIEL   (Germany)

^p MEDICAL UNIVERSITY OF LODZ   (Poland)

^q POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^r EPILEPSY SOCIETY   (United Kingdom)

^s MONTREAL CHILDREN S HOSPITAL   (Canada)

^t RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

more..

Author keywords

Brain development; Epilepsy; FGFR signaling; Molecular etiology; Targeted therapy; Whole exome sequencing

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; B RAF KINASE; FGFR1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CELL CULTURE; COMPARATIVE STUDY; COMPUTER MODEL; COPY NUMBER VARIATION; DNA ISOLATION; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; EXOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENE FREQUENCY; GENE SEQUENCE; GENOME ANALYSIS; GERMLINE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MUTATION RATE; NEUROEPITHELIOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; SENESCENCE; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR RECURRENCE; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION; BRAIN TUMOR; GENETICS; GLIOMA; HEK293 CELL LINE; MAPK SIGNALING; MUTATION; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; GLIOMA; HEK293 CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; YOUNG ADULT;

EID: 84969645471     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1549-x     Document Type: Article

References (42)

1. Bae JH, Boggon TJ, Tome F, Mandiyan V, Lax I, Schlessinger J (2010) Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells. Proc Natl Acad Sci USA 107:2866–2871. doi:10.1073/pnas.0914157107
2. Barba C, Jacques T, Kahane P, Polster T, Isnard J, Leijten FS, Ozkara C, Tassi L, Giordano F, Castagna M, John A, Oz B, Salon C, Streichenberger N, Cross JH, Guerrini R (2013) Epilepsy surgery in Neurofibromatosis Type 1. Epilepsy Res 105:384–395. doi:10.1016/j.eplepsyres.2013.02.021
3. Blümcke I, Aronica E, Urbach H, Alexopoulos A, Gonzalez-Martinez JA (2014) A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors. Acta Neuropathol 128:39–54. doi:10.1007/s00401-014-1288-9
4. Chappe C, Padovani L, Scavarda D, Forest F, Nanni-Metellus I, Loundou A, Mercurio S, Fina F, Lena G, Colin C, Figarella-Branger D (2013) Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol 23:574–583. doi:10.1111/bpa.12048
5. Chen H, Ma J, Li W, Eliseenkova AV, Xu C, Neubert TA, Miller WT, Mohammadi M (2007) A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell 27:717–730. doi:10.1016/j.molcel.2007.06.028
6. Daumas-Duport CPT, Hawkins C, Shankar SK (2007) Dysembryoplastic neuroepithelial tumors. In: Louis DNOH, Wiestler OD, Cavanee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, pp 99–102
7. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. doi:10.1093/bioinformatics/bts635
8. Fiskus W, Mitsiades N (2016) B-Raf inhibition in the clinic: present and future. Annu Rev Med 67:29–43. doi:10.1146/annurev-med-090514-030732
9. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O’Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809–819. doi:10.1056/NEJMoa1002011
10. Fontebasso AM, Schwartzentruber J, Khuong-Quang DA, Liu XY, Sturm D, Korshunov A, Jones DT, Witt H, Kool M, Albrecht S, Fleming A, Hadjadj D, Busche S, Lepage P, Montpetit A, Staffa A, Gerges N, Zakrzewska M, Zakrzewski K, Liberski PP, Hauser P, Garami M, Klekner A, Bognar L, Zadeh G, Faury D, Pfister SM, Jabado N, Majewski J (2013) Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 125:659–669. doi:10.1007/s00401-013-1095-8
11. Fromer M, Moran JL, Chambert K, Banks E, Bergen SE, Ruderfer DM, Handsaker RE, McCarroll SA, O’Donovan MC, Owen MJ, Kirov G, Sullivan PF, Hultman CM, Sklar P, Purcell SM (2012) Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet 91:597–607. doi:10.1016/j.ajhg.2012.08.005
12. Gessi M, Moneim YA, Hammes J, Goschzik T, Scholz M, Denkhaus D, Waha A, Pietsch T (2014) FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle. J Neuropathol Exp Neurol 73:580–584. doi:10.1097/NEN.0000000000000080
13. Goetz R, Mohammadi M (2013) Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol 14:166–180. doi:10.1038/nrm3528
14. Goriely A, McVean GA, van Pelt AM, O’Rourke AW, Wall SA, de Rooij DG, Wilkie AO (2005) Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci USA 102:6051–6056. doi:10.1073/pnas.0500267102
15. Hasselblatt M, Kurlemann G, Rickert CH, Debus OM, Brentrup A, Schachenmayr W, Paulus W (2004) Familial occurrence of dysembryoplastic neuroepithelial tumor. Neurology 62:1020–1021
16. Ho CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, Mason GE, Bornhorst M, Esbenshade AJ, Tehrani M, Orr BA, LaFrance DR, Devaney JM, Meltzer BW, Hofherr SE, Burger PC, Packer RJ, Rodriguez FJ (2015) A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Acta Neuropathol 130:575–585. doi:10.1007/s00401-015-1467-3
17. Jones DT, Hutter B, Jager N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stutz AM, Hutter S, Zuckermann M, Sturm D, Gronych J, Lasitschka B, Schmidt S, Seker-Cin H, Witt H, Sultan M, Ralser M, Northcott PA, Hovestadt V, Bender S, Pfaff E, Stark S, Faury D, Schwartzentruber J, Majewski J, Weber UD, Zapatka M, Raeder B, Schlesner M, Worth CL, Bartholomae CC, von Kalle C, Imbusch CD, Radomski S, Lawerenz C, van Sluis P, Koster J, Volckmann R, Versteeg R, Lehrach H, Monoranu C, Winkler B, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, Ebinger M, Schuhmann MU, Cho YJ, Pomeroy SL, von Deimling A, Witt O, Taylor MD, Wolf S, Karajannis MA, Eberhart CG, Scheurlen W, Hasselblatt M, Ligon KL, Kieran MW, Korbel JO, Yaspo ML, Brors B, Felsberg J, Reifenberger G, Collins VP, Jabado N, Eils R, Lichter P, Pfister SM, International Cancer Genome Consortium PedBrain Tumor P (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927–932. doi:10.1038/ng.2682
18. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih Ie M, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110:6021–6026. doi:10.1073/pnas.1303607110
19. Li H (2011) A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27:2987–2993. doi:10.1093/bioinformatics/btr509
20. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25:1754–1760. doi:10.1093/bioinformatics/btp324
21. Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, Stebbings L, Menzies A, Widaa S, Stratton MR, Jones PH, Campbell PJ (2015) Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348:880–886. doi:10.1126/science.aaa6806
22. Marucci G, de Biase D, Visani M, Giulioni M, Martinoni M, Volpi L, Riguzzi P, Rubboli G, Michelucci R, Tallini G (2014) Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia. Ann Clin Transl Neurol 1:130–134. doi:10.1002/acn3.31
23. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297–1303. doi:10.1101/gr.107524.110
24. McWilliams GD, SantaCruz K, Hart B, Clericuzio C (2015) Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy. Am J Med Genet A 9999:1–7. doi:10.1002/ajmg.a.37379
25. Mohammadi M, Schlessinger J, Hubbard SR (1996) Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86:577–587
26. Nadaf J, Majewski J, Fahiminiya S (2015) ExomeAI: detection of recurrent allelic imbalance in tumors using whole-exome sequencing data. Bioinformatics 31:429–431. doi:10.1093/bioinformatics/btu665
27. Neault M, Mallette FA, Vogel G, Michaud-Levesque J, Richard S (2012) Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res 40:9513–9521. doi:10.1093/nar/gks764
28. Passos-Bueno MR, Wilcox WR, Jabs EW, Sertie AL, Alonso LG, Kitoh H (1999) Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 14:115–125. doi:10.1002/(SICI)1098-1004(1999)14:2<115:AID-HUMU3>3.0.CO;2-2
29. Prabowo AS, van Thuijl HF, Scheinin I, Sie D, van Essen HF, Iyer AM, Spliet WG, Ferrier CH, van Rijen PC, Veersema TJ, Thom M, Schouten-van Meeteren AY, Reijneveld JC, Ylstra B, Wesseling P, Aronica E (2015) Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours. Neuropathol Appl Neurobiol. doi:10.1111/nan.12235
30. Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J, Mulder H, Boggs K, Shao Y, Rusch M, Becksfort J, Gupta P, Wang S, Lee RP, Brat D, Peter Collins V, Dahiya S, George D, Konomos W, Kurian KM, McFadden K, Serafini LN, Nickols H, Perry A, Shurtleff S, Gajjar A, Boop FA, Klimo PD Jr, Mardis ER, Wilson RK, Baker SJ, Zhang J, Wu G, Downing JR, Tatevossian RG, Ellison DW (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol. doi:10.1007/s00401-016-1539-z
31. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24–26. doi:10.1038/nbt.1754
32. Saito TS, Sugiyama K, Yamasaki F, Tominaga A, Kurisu K, Takeshima Y, Hirose T (2008) Familial occurrence of dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: case report. Neurosurgery 63:e370–e372. doi:10.1227/01.NEU.0000320421.82255.63(discussion e372)
33. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, Qiu K, Gao Z, Ceccarelli M, Riccardi R, Brat DJ, Guha A, Aldape K, Golfinos JG, Zagzag D, Mikkelsen T, Finocchiaro G, Lasorella A, Rabadan R, Iavarone A (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337:1231–1235. doi:10.1126/science.1220834
34. Thom M, Toma A, An S, Martinian L, Hadjivassiliou G, Ratilal B, Dean A, McEvoy A, Sisodiya SM, Brandner S (2011) One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 70:859–878. doi:10.1097/NEN.0b013e3182302475
35. Touat M, Ileana E, Postel-Vinay S, Andre F, Soria JC (2015) Targeting FGFR signaling in cancer. Clin Cancer Res 21:2684–2694. doi:10.1158/1078-0432.CCR-14-2329
36. Turner CA, Eren-Kocak E, Inui EG, Watson SJ, Akil H (2015) Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders. Semin Cell Dev Biol. doi:10.1016/j.semcdb.2015.10.003
37. Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:116–129. doi:10.1038/nrc2780
38. Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, Siebert R (2006) FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8:141–151. doi:10.2353/jmoldx.2006.050083
39. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164. doi:10.1093/nar/gkq603
40. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z (2009) Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25:2865–2871. doi:10.1093/bioinformatics/btp394
41. Yoon K, Nery S, Rutlin ML, Radtke F, Fishell G, Gaiano N (2004) Fibroblast growth factor receptor signaling promotes radial glial identity and interacts with Notch1 signaling in telencephalic progenitors. J Neurosci 24:9497–9506. doi:10.1523/JNEUROSCI.0993-04.2004
42. Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I, Boop FA, Lu C, Kandoth C, Ding L, Lee R, Huether R, Chen X, Hedlund E, Nagahawatte P, Rusch M, Boggs K, Cheng J, Becksfort J, Ma J, Song G, Li Y, Wei L, Wang J, Shurtleff S, Easton J, Zhao D, Fulton RS, Fulton LL, Dooling DJ, Vadodaria B, Mulder HL, Tang C, Ochoa K, Mullighan CG, Gajjar A, Kriwacki R, Sheer D, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Baker SJ, Ellison DW, St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome P (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612. doi:10.1038/ng.2611